bso glutathione inhibitor Combined inhibition of de novo and nucleotide biosynthesis is synthetically lethal in glioblastoma CAS 5072 Buthionine sulfoximine - Enzo
Buthionine sulfoximine Enzo Sigma Aldrich Buthionine sulfoximine, CAS 5072 26 4, 99.0% (TLC) 250 mg The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal Combination studies of platinum( ii ) based metallointercalators with buthionine S , R sulfoximine, 3 bromopyruvate, cisplatin or carboplatin Metallomics (RSC Publishing) DOI:10.1039 C3MT00191A Differentiating Changes in Glutathione Levels from Cytotoxic Events Using Multiplexed Assays
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




